Sepp-Lorenzino Laura Insider Trades

Insider Trading History

Track insider trading activity for Sepp-Lorenzino Laura. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Director
Holding Value $725k 127,178 shares
Last Trade
Jun 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$382k 64,006 shares
$5.97
$5.70
Lexeo Therapeutics
Lexeo Therapeutics LXEO
Director
Holding Value $231k 50,000 shares
Last Trade
Apr 28, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$291k 50,000 shares
$5.81
$4.62
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Director
Holding Value $646k 113,246 shares
Last Trade
Jun 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$316k 113,246 shares
$2.79
$5.70
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Scientific Officer
Holding Value $1.01M 77,388 shares
Last Trade
Jan 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$109k 8,966 shares
$12.18
$13.04
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Scientific Officer
Holding Value $0 0 shares
Last Trade
Jan 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$40.8k 3,500 shares
$11.66
$13.04
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Scientific Officer
Holding Value $1.13M 86,354 shares
Last Trade
Jan 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$40.8k 3,500 shares
$11.66
$13.04
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Director
Holding Value $561k 98,440 shares
Last Trade
May 29, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$312k 98,440 shares
$3.17
$5.70
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Scientific Officer
Holding Value $1.07M 81,893 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.79M 54,794 shares
$32.66
$13.04
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Scientific Officer
Holding Value $582k 44,594 shares
Last Trade
Jan 08, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$65.7k 2,275 shares
$28.87
$13.04
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Scientific Officer
Holding Value $602k 46,202 shares
Last Trade
Jan 03, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$163k 5,532 shares
$29.46
$13.04
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Scientific Officer
Holding Value $675k 51,734 shares
Last Trade
Jan 01, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$107k 3,500 shares
$30.49
$13.04
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Scientific Officer
Holding Value $45.6k 3,500 shares
Last Trade
Jan 01, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$107k 3,500 shares
$30.49
$13.04
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Director
Holding Value $206k 36,200 shares
Last Trade
Jun 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.1k 36,200 shares
$0.72
$5.70
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Scientific Officer
Holding Value $620k 47,567 shares
Last Trade
Mar 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.72M 42,302 shares
$40.75
$13.04
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Scientific Officer
Holding Value $239k 18,318 shares
Last Trade
Jan 05, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$89.7k 2,330 shares
$38.48
$13.04
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Scientific Officer
Holding Value $260k 19,959 shares
Last Trade
Jan 04, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$93.3k 2,508 shares
$37.21
$13.04
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Scientific Officer
Holding Value $293k 22,467 shares
Last Trade
Jan 01, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$122k 3,500 shares
$34.89
$13.04
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Scientific Officer
Holding Value $91.3k 7,000 shares
Last Trade
Jan 01, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$122k 3,500 shares
$34.89
$13.04
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Director
Holding Value $88.4k 15,500 shares
Last Trade
Jun 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$43.6k 15,500 shares
$2.81
$5.70
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Scientific Officer
Holding Value $243k 18,631 shares
Last Trade
Mar 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.1M 13,816 shares
$79.85
$13.04

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up